That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

Michael W. Michelson net worth and biography

Michael Michelson Biography and Net Worth

Director of Zimmer Biomet

Senior Advisory Partner, KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P., from January 2018 until his retirement in January 2020. Previously, Member, KKR Management LLC since October 2009. Before that, Mr. Michelson was a member of the limited liability company that served as the general partner of Kohlberg Kravis Roberts & Co. L.P. since 1996. He joined KKR in 1981. Mr. Michelson has played a significant role in the development of KKR’s portfolio companies. He began his professional career with the law firm of Latham & Watkins in Los Angeles, where he was involved in a broad corporate practice while specializing in management buyouts. He earned an A.B. from Harvard College and a J.D. from Harvard Law School.

What is Michael W. Michelson's net worth?: The estimated net worth of Michael W. Michelson is at least $370,014.35 as of August 25th, 2023. Mr. Michelson owns 3,385 shares of Zimmer Biomet stock worth more than $370,014 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Michelson may own. Learn More about Michael W. Michelson's net worth.
How do I contact Michael W. Michelson?: The corporate mailing address for Mr. Michelson and other Zimmer Biomet executives is 345 EAST MAIN STREET, WARSAW IN, 46580. Zimmer Biomet can also be reached via phone at (574) 267-6131 and via email at [email protected]. Learn More on Michael W. Michelson's contact information.
Has Michael W. Michelson been buying or selling shares of Zimmer Biomet?: Michael W. Michelson has not been actively trading shares of Zimmer Biomet during the last ninety days. Most recently, on Friday, August 25th, Michael W. Michelson bought 1,300 shares of Zimmer Biomet stock. The stock was acquired at an average cost of $115.50 per share, with a total value of $150,150.00. Following the completion of the transaction, the director now directly owns 3,385 shares of the company's stock, valued at $390,967.50. Learn More on Michael W. Michelson's trading history.
Who are Zimmer Biomet's active insiders?: Zimmer Biomet's insider roster includes Betsy Bernard (Director), Wilfred can Zuilen (Insider), Robert Hagemann (Director), Bryan Hanson (CEO), Arthur Higgins (Director), Sreelakshmi Kolli (Director), Michael Michelson (Director), Chad Phipps (VP), and Sang Yi (Insider). Learn More on Zimmer Biomet's active insiders.
Are insiders buying or selling shares of Zimmer Biomet?: During the last year, insiders at the medical equipment provider sold shares 1 times. They sold a total of 26,156 shares worth more than $3,364,184.72. The most recent insider tranaction occured on February, 22nd when VP Chad F Phipps sold 26,156 shares worth more than $3,364,184.72. Insiders at Zimmer Biomet own 0.7% of the company. Learn More about insider trades at Zimmer Biomet.
Information on this page was last updated on 2/22/2024.

Michael W. Michelson Insider Trading History at Zimmer Biomet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/25/2023	Buy	1,300	$115.50	$150,150.00	3,385
2/8/2019	Buy	2,085	$119.69	$249,553.65	2,085

Michael W. Michelson Buying and Selling Activity at Zimmer Biomet

Zimmer Biomet Company Overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $109.31

$109.08

$110.81

50 Day Range

MA: $106.65

$101.77

$113.02

2 Week Range

Now: $109.31

$101.47

$133.90

Volume

1,476,375 shs

Average Volume

1,660,116 shs

Market Capitalization

$21.76 billion

P/E Ratio

20.78

Dividend Yield

0.87%

Beta

1.02

Tesla Execs are Freaking Out

From Angel Publishing | Ad

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Click here to get the details.